448 related articles for article (PubMed ID: 16885356)
1. Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.
Shelton DN; Sandoval IT; Eisinger A; Chidester S; Ratnayake A; Ireland CM; Jones DA
Cancer Res; 2006 Aug; 66(15):7571-7. PubMed ID: 16885356
[TBL] [Abstract][Full Text] [Related]
2. Dual roles for adenomatous polyposis coli in regulating retinoic acid biosynthesis and Wnt during ocular development.
Nadauld LD; Chidester S; Shelton DN; Rai K; Broadbent T; Sandoval IT; Peterson PW; Manos EJ; Ireland CM; Yost HJ; Jones DA
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13409-14. PubMed ID: 16938888
[TBL] [Abstract][Full Text] [Related]
3. Adenomatous polyposis coli control of retinoic acid biosynthesis is critical for zebrafish intestinal development and differentiation.
Nadauld LD; Sandoval IT; Chidester S; Yost HJ; Jones DA
J Biol Chem; 2004 Dec; 279(49):51581-9. PubMed ID: 15358764
[TBL] [Abstract][Full Text] [Related]
4. The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid.
Eisinger AL; Nadauld LD; Shelton DN; Peterson PW; Phelps RA; Chidester S; Stafforini DM; Prescott SM; Jones DA
J Biol Chem; 2006 Jul; 281(29):20474-82. PubMed ID: 16699180
[TBL] [Abstract][Full Text] [Related]
5. T-cell factor 4 (tcf7l2) is the main effector of Wnt signaling during zebrafish intestine organogenesis.
Faro A; Boj SF; Ambrósio R; van den Broek O; Korving J; Clevers H
Zebrafish; 2009 Mar; 6(1):59-68. PubMed ID: 19374549
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
[TBL] [Abstract][Full Text] [Related]
7. A two-step model for colon adenoma initiation and progression caused by APC loss.
Phelps RA; Chidester S; Dehghanizadeh S; Phelps J; Sandoval IT; Rai K; Broadbent T; Sarkar S; Burt RW; Jones DA
Cell; 2009 May; 137(4):623-34. PubMed ID: 19450512
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor adenomatous polyposis coli and caudal related homeodomain protein regulate expression of retinol dehydrogenase L.
Jette C; Peterson PW; Sandoval IT; Manos EJ; Hadley E; Ireland CM; Jones DA
J Biol Chem; 2004 Aug; 279(33):34397-405. PubMed ID: 15190067
[TBL] [Abstract][Full Text] [Related]
11. The zebrafish retinol dehydrogenase, rdh1l, is essential for intestinal development and is regulated by the tumor suppressor adenomatous polyposis coli.
Nadauld LD; Shelton DN; Chidester S; Yost HJ; Jones DA
J Biol Chem; 2005 Aug; 280(34):30490-5. PubMed ID: 15967793
[TBL] [Abstract][Full Text] [Related]
12. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
13. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.
Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P
Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383
[TBL] [Abstract][Full Text] [Related]
15. Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation.
van den Brink GR; Bleuming SA; Hardwick JC; Schepman BL; Offerhaus GJ; Keller JJ; Nielsen C; Gaffield W; van Deventer SJ; Roberts DJ; Peppelenbosch MP
Nat Genet; 2004 Mar; 36(3):277-82. PubMed ID: 14770182
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish.
Valvezan AJ; Huang J; Lengner CJ; Pack M; Klein PS
Dis Model Mech; 2014 Jan; 7(1):63-71. PubMed ID: 24092877
[TBL] [Abstract][Full Text] [Related]
17. Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling.
Arimura S; Matsunaga A; Kitamura T; Aoki K; Aoki M; Taketo MM
Gastroenterology; 2009 Aug; 137(2):629-38. PubMed ID: 19427313
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
[TBL] [Abstract][Full Text] [Related]
19. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of
Delacruz RGC; Sandoval IT; Chang K; Miller BN; Reyes-Uribe L; Borras E; Lynch PM; Taggart MW; Hawk ET; Vilar E; Jones DA
Oncotarget; 2019 Jun; 10(39):3939-3951. PubMed ID: 31231471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
